Curtis Hanson, M.D., Elected as ACLA Chair - Insights
At the recent American Clinical Laboratory Association (ACLA) annual meeting, Curt Hanson, M.D., Chief Medical Officer at Mayo Medical Laboratories, was elected as Chair of the ACLA Board.
Mayo Clinic Laboratory and pathology research roundup: December 6 - Insights
This week's research roundup features: Clinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation
Mayo Clinic Laboratory and pathology research roundup: March 7 - Insights
This week's Research Roundup features: Membranous nephropathy in syphilis is associated with neuron-derived neurotrophic factor.
Cases with Dr. Keeney: Case #4 - Insights
This case presents a female patient in her 70s with pain in the right upper quadrant. An ultrasound showed pelviectasis bilaterally, right greater than left. What is the diagnosis?
Maria Alice Willrich, Ph.D., Discusses Therapeutic Monoclonal Antibodies - Insights
Maria Alice Willrich, Ph.D., was featured in an article in "360Dx" discussing therapeutic monoclonal antibodies (t-mAbs).
Bobbi Pritt, M.D., Advises Pathologists on Parasite Identification - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, was recently featured in an article in CAP TODAY...
Blood clots in the heart are common in patients with COVID-19 - Insights
A small but in-depth study conducted a postmortem evaluation of the heart tissue of 15 patients with COVID-19, including the first postmortem cardiac findings of three patients who had cleared the virus.
William Morice II, M.D., Ph.D., discusses COVID-19 testing in The Wall Street Journal - Insights
Dr. Morice, president of Mayo Clinic Laboratories, weighs in on the role of testing and addresses how quickly a COVID-19 infection can be detected.
William Morice II, M.D., Ph.D., discusses progress in COVID-19 vaccine development - Insights
In a story on Washington D.C. Fox 5 News, Dr. Morice reviewed the significance of reports that a COVID-19 vaccine was found to be more than 90% effective.
Matthew Binnicker, Ph.D., weighs in on pooled molecular testing for SARS-CoV-2 - Insights
At the beginning of the pandemic, pooled testing was seen as a way to potentially conserve valuable testing resources, but logistical hurdles and other challenges have limited its usefulness.